Ohio Reaches Opioid Settlement
Ohio Attorney General Dave Yost and 21 other attorneys general have final approval of a combined $17.3 billion settlement from drug-makers Teva and Allergan and pharmacies CVS and Walgreens for their role in the opioid-addiction crisis. The settlement will help pay for ongoing recovery efforts.
Ohio is expected to receive $679.6 million over 15 years. The settlement money is due to start being paid to the states and local governments by the end of 2023.
The money will be distributed through the OneOhio plan: 55% of Ohio’s portion will go to the OneOhio Recovery Foundation, 30% to local governments, and 15% to the state. Ohio’s $679.6 million allotment breaks down this way:
- $156 million over 13 years from Teva
- $93 million over seven years from Allergan
- $206.3 million over 10 years from CVS
- $224.3 million over 15 years from Walgreens
The final agreement with the attorneys general also requires:
- Teva’s opioid business to prevent all opioid marketing and ensure systems are in place to prevent drug misuse
- Allergan to stop selling opioids for the next 10 years
- CVS and Walgreens pharmacies to monitor, report, and share data about suspicious activity related to opioid prescriptions